Allen H. Heller

3.5k total citations · 1 hit paper
48 papers, 2.5k citations indexed

About

Allen H. Heller is a scholar working on Pharmacology, Surgery and Psychiatry and Mental health. According to data from OpenAlex, Allen H. Heller has authored 48 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 14 papers in Surgery and 12 papers in Psychiatry and Mental health. Recurrent topics in Allen H. Heller's work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Epilepsy research and treatment (11 papers) and Antibiotic Resistance in Bacteria (9 papers). Allen H. Heller is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (15 papers), Epilepsy research and treatment (11 papers) and Antibiotic Resistance in Bacteria (9 papers). Allen H. Heller collaborates with scholars based in United States, Germany and United Kingdom. Allen H. Heller's co-authors include Harry M. Olson, A. M. Monro, Graham R. Betton, Karluss Thomas, William M. Bracken, Peter J. Smith, Bruce M. Berger, Michael A. Dorato, Patrick D. Lilly and Gerald J. Kolaja and has published in prestigious journals such as Nature, Journal of the American College of Cardiology and Neurology.

In The Last Decade

Allen H. Heller

47 papers receiving 2.3k citations

Hit Papers

Concordance of the Toxicity of Pharmaceuticals in Humans ... 2000 2026 2008 2017 2000 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals
    2000 1.4k citations Harry M. Olson, Graham R. Betton et al. Regulatory Toxicology and Pharmacology profile →

Peers

Allen H. Heller
W. Meuldermans Belgium
C.T. Viswanathan United States
Iain J. McGilveray Canada
Francis L. S. Tse Japan
Don K. Walker United Kingdom
A. M. Monro United States
Daryl J. Murry United States
Ruben de Kanter Switzerland
J. Heykants Belgium
Michael A. Dorato United States
W. Meuldermans Belgium
Allen H. Heller
Citations per year, relative to Allen H. Heller Allen H. Heller (= 1×) peers W. Meuldermans

Countries citing papers authored by Allen H. Heller

Since Specialization
Citations

This map shows the geographic impact of Allen H. Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen H. Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen H. Heller more than expected).

Fields of papers citing papers by Allen H. Heller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allen H. Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen H. Heller. The network helps show where Allen H. Heller may publish in the future.

Co-authorship network of co-authors of Allen H. Heller

This figure shows the co-authorship network connecting the top 25 collaborators of Allen H. Heller. A scholar is included among the top collaborators of Allen H. Heller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allen H. Heller. Allen H. Heller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rogawski, Michael A., et al.. (2020). Pharmacokinetics of Diazepam Buccal Film in Adult Patients with Epilepsy: Comparison with Diazepam Rectal Gel (4437). Neurology. 94(15_supplement). 1 indexed citations
2.
3.
Heller, Allen H., et al.. (2018). Safety and Pharmacokinetics of Diazepam Buccal Soluble Film (P4.272). Neurology. 90(15_supplement). 2 indexed citations
4.
Isaacsohn, Jonathan L., et al.. (2001). Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults. European Journal of Clinical Pharmacology. 56(12). 897–903. 5 indexed citations
5.
Barrett, Jeffrey S., Vijay Batra, Andrew Chow, et al.. (2000). Update to the PhRMA Perspective on Population and Individual Bioequivalence. The Journal of Clinical Pharmacology. 40(6). 571–572. 5 indexed citations
6.
Olson, Harry M., Graham R. Betton, Denise E. Robinson, et al.. (2000). Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals. Regulatory Toxicology and Pharmacology. 32(1). 56–67. 1417 indexed citations breakdown →
7.
8.
Mazzu, Arthur, John Lettieri, Lee Kaiser, William S. Mullican, & Allen H. Heller. (1998). Influence of Age on the Safety, Tolerability, and Pharmacokinetics of the Novel HMG‐CoA Reductase Inhibitor Cerivastatin in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 38(8). 715–719. 4 indexed citations
9.
Stein, Evan A., et al.. (1998). Efficacy and safety of 0.8 mg dosage of cerivastatin, a novel HMG-CoA reductase inhibitor. Journal of the American College of Cardiology. 31. 281–281. 7 indexed citations
10.
Bischoff, Hilmar & Allen H. Heller. (1998). Preclinical and clinical pharmacology of cerivastatin. The American Journal of Cardiology. 82(4). 18J–25J. 31 indexed citations
11.
Persson, Jan, et al.. (1997). Systemic Absorption and Block after Epidural Injection of Ropivacaine in Healthy Volunteers . Anesthesiology. 87(6). 1309–1317. 55 indexed citations
12.
Israel, Debra S., Jennifer L. Stotka, William Rock, et al.. (1996). Effect of Ciprofloxacin on the Pharmacokinetics and Pharmacodynamics of Warfarin. Clinical Infectious Diseases. 22(2). 251–256. 41 indexed citations
13.
Shah, P. M., Angelika Böhme, Reiner Schaumann, et al.. (1996). Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients. Infection. 24(6). 480–484. 20 indexed citations
14.
Shah, Anita, et al.. (1996). Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects. Journal of Antimicrobial Chemotherapy. 38(1). 103–116. 26 indexed citations
15.
Shah, Anita, G.J. Krol, P. R. Sundaresan, et al.. (1995). PHARMACOKINETICS OF NISOLDIPINE COAT-CORE FORMULATION IN SUBJECTS WITH LIVER CIRRHOSIS. American Journal of Therapeutics. 2(1). 15–19. 3 indexed citations
16.
Sramek, John J., Allen H. Heller, P. R. Sundaresan, et al.. (1994). Safety and Tolerance of Intravenous Nimodipine. Annals of Pharmacotherapy. 28(10). 1143–1148. 4 indexed citations
17.
Lettieri, John, et al.. (1994). Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg po twice daily. Journal of Antimicrobial Chemotherapy. 33(4). 795–801. 32 indexed citations
18.
Echols, Roger, et al.. (1994). Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin. Journal of Antimicrobial Chemotherapy. 33(1). 111–118. 9 indexed citations
19.
Lettieri, John, Lee Kaiser, G.J. Krol, & Allen H. Heller. (1993). Comparative Pharmacokinetics of Oral and Intravenous Ciprofloxacin. Drugs. 45(Supplement 3). 271–272. 1 indexed citations
20.
Cutler, Neal R., et al.. (1991). Idioventricular Rhythm: Hypervagotonia Associated with Placebo. DICP. 25(5). 471–472. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Meuldermans Breakdown of academic impact, for papers by C.T. Viswanathan Breakdown of academic impact, for papers by Iain J. McGilveray Breakdown of academic impact, for papers by Francis L. S. Tse Breakdown of academic impact, for papers by Don K. Walker Breakdown of academic impact, for papers by A. M. Monro Breakdown of academic impact, for papers by Daryl J. Murry Breakdown of academic impact, for papers by Ruben de Kanter Breakdown of academic impact, for papers by J. Heykants Breakdown of academic impact, for papers by Michael A. Dorato
Rankless by CCL
2026